NeoGenomics Inc Sustainability Reports
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories that provide genetic and molecular testing services. It serves oncologists, pathologists, pharmaceutical companies, and clinical trial sponsors with diagnostic and research tools.
Sector: Healthcare & social services
Country: United States
Exchange: Nasdaq
LEI: 254900KXWYZIKXNFT521
FIGI: BBG001S9DSY4
10 reports from 2012 to 2024
